Herbalife reaffirms FY 2026 adjusted EBITDA outlook of 670-690 million - HLF News | RalliesHerbalife reaffirms FY 2026 adjusted EBITDA outlook of 670-690 million
H
HLF• FY 2026 and Q3 2026 guidance reaffirmed
- Herbalife reaffirmed Q3 2026 guidance for net sales growth of 0.5% to 4.5% year over year.
- Adjusted EBITDA forecast set at 160-180; CapEx expected at 15-25.
- On a constant-currency basis, net sales growth seen at 1.5% to 5.5%; adjusted EBITDA at 165-185.
- Full-year 2026 outlook maintained for net sales growth of 2.5% to 5.5%; adjusted EBITDA of 670-690.
- FY 2025 net sales were 5.04 billion; adjusted EBITDA was 657.6 million; Q3 2025 net sales were 1.27 billion.
